Deliver Consulting Limited | Back to main site

Speaker Short Biography

  • Liandong Ma

    Vice President and President of R&D

    Kintor Pharmaceuticals

    Short Biography

    Dr. Liandong Ma, joined Suzhou Kintor Pharmaceuticals, Inc., as Vice President and President of the Institute of R&D, Suzhou Kintor Pharmaceuticals, Suzhou, China in 2018. He is primarily responsible for early phase Drug Discovery and Development as well as Patient Tailoring and Translational Medicine. He has led Kintor R&D team to deliver 5 IND projects and three clinical development projects, including leading Covide-19 clinical study in Brazil. Before Liandong joined Kintor, he had worked as a Senior Research Scientist in Oncology Department, Eli Lilly and Company for 20 years. He led and involved more than 10 Oncology Drug Discovery projects at Lilly, including 4 clinical candidates, of which LY335979, a drug transport inhibitor and Gandotinib (LY2784544), a JAK2 small molecule inhibitor, had been evaluated in phase II clinical trials. After Liandong’s employment with Lilly, he worked as a Senior Scientific Advisor for Janpix, a JAK-STAT Inhibitor Company (Cambridge, MA). Liandong’s academic career included undergraduate and graduate work in China followed by post-doctoral work in Immunology Lab at Massachusetts General Hospital, Harvard Medical School; Biology Department at Kinases State University; and Cell Biology Department at Southwestern Medical Center at Dallas. Liandong is active members of Association of American Cancer Research and American Society of Hematology. He has published more than 10 Journal articles and 20 FDA study reports and is also an inventor of Gandotinib patent.